dipyridamole- dipyridamole injection, solution
hospira, inc. - dipyridamole (unii: 64alc7f90c) (dipyridamole - unii:64alc7f90c) - injection, solution - dipyridamole injection is indicated as an alternative to exercise in thallium myocardial perfusion imaging for the evaluation of coronary artery disease in patients who cannot exercise adequately. in a study of about 1100 patients who underwent coronary arteriography and dipyridamole injection assisted thallium imaging, the results of both tests were interpreted blindly and the sensitivity and specificity of the dipyridamole thallium study in predicting the angiographic outcome were calculated. the sensitivity of the dipyridamole test (true positive dipyridamole divided by the total number of patients with positive angiography) was about 85%. the specificity (true negative divided by the number of patients with negative angiograms) was about 50%. in a subset of patients who had exercise thallium imaging as well as dipyridamole thallium imaging, sensitivity and specificity of the two tests was almost identical. hypersensitivity to dipyridamole.
dipyridamole injection
general injectables & vaccines, inc - dipyridamole (unii: 64alc7f90c) (dipyridamole - unii:64alc7f90c) - dipyridamole 5 mg in 1 ml - dipyridamole injection is indicated as an alternative to exercise in thallium myocardial perfusion imaging for the evaluation of coronary artery disease in patients who cannot exercise adequately. in a study of about 1100 patients who underwent coronary arteriography and dipyridamole injection assisted thallium imaging, the results of both tests were interpreted blindly and the sensitivity and specificity of the dipyridamole thallium study in predicting the angiographic outcome were calculated. the sensitivity of the dipyridamole test (true positive dipyridamole divided by the total number of patients with positive angiography) was about 85%. the specificity (true negative divided by the number of patients with negative angiograms) was about 50%. in a subset of patients who had exercise thallium imaging as well as dipyridamole thallium imaging, sensitivity and specificity of the two tests were almost identical. hypersensitivity to dipyridamole.
dipyridamole tablet, film coated
lannett company, inc. - dipyridamole (unii: 64alc7f90c) (dipyridamole - unii:64alc7f90c) - dipyridamole 25 mg - dipyridamole tablets, usp are indicated as an adjunct to coumarin anticoagulants in the prevention of postoperative thromboembolic complications of cardiac valve replacement. hypersensitivity to dipyridamole and any of the other components.
dipyridamole tablet, film coated
zydus pharmaceuticals usa inc. - dipyridamole (unii: 64alc7f90c) (dipyridamole - unii:64alc7f90c) - dipyridamole 25 mg - dipyridamole tablets are indicated as an adjunct to coumarin anticoagulants in the prevention of postoperative thromboembolic complications of cardiac valve replacement. hypersensitivity to dipyridamole and any of the other components.
dipyridamole tablet, film coated
zydus lifesciences limited - dipyridamole (unii: 64alc7f90c) (dipyridamole - unii:64alc7f90c) - dipyridamole 25 mg - dipyridamole tablets are indicated as an adjunct to coumarin anticoagulants in the prevention of postoperative thromboembolic complications of cardiac valve replacement. hypersensitivity to dipyridamole and any of the other components.
dipyridamole tablet, film coated
ncs healthcare of ky, inc dba vangard labs - dipyridamole (unii: 64alc7f90c) (dipyridamole - unii:64alc7f90c) - dipyridamole 50 mg - dipyridamole tablets are indicated as an adjunct to coumarin anticoagulants in the prevention of postoperative thromboembolic complications of cardiac valve replacement. hypersensitivity to dipyridamole and any of the other components.
dipyridamole tablet, film coated
rising pharmaceuticals, inc. - dipyridamole (unii: 64alc7f90c) (dipyridamole - unii:64alc7f90c) - dipyridamole 25 mg - dipyridamole tablets are indicated as an adjunct to coumarin anticoagulants in the prevention of postoperative thromboembolic complications of cardiac valve replacement. hypersensitivity to dipyridamole and any of the other components.
dipyridamole 200mg modified-release capsules
a a h pharmaceuticals ltd - dipyridamole - modified-release capsule - 200mg
dipyridamole 200mg/5ml oral
syri limited, t/a thame laboratories - dipyridamole - oral suspension - 200/5 mg/ml - dipyridamole
dipyridamole 100mg/5ml oral suspension
martindale pharmaceuticals limited bampton road, harold hill, romford essex, rm3 8ug, united kingdom - dipyridamole - oral suspension - dipyridamole 100 mg/5ml - antithrombotic agents